President of Health Services Chernin Ethan covered exercise/tax liability with 1,332 shares and was granted 20,914 shares, increasing direct ownership by 119% to 35,988 units (SEC Form 4)

$ARDT
Hospital/Nursing Management
Health Care
Get the next $ARDT alert in real time by email
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chernin Ethan

(Last) (First) (Middle)
340 SEVEN SPRINGS WAY, SUITE 100

(Street)
BRENTWOOD TN 37027

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Ardent Health Partners, Inc. [ ARDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President of Health Services
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/31/2025 F 1,332(1) D $13.75(2) 15,074 D
Common Stock 04/01/2025 A 20,914(3) A $0 35,988 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3
2. Represents the closing price of the common stock of the Issuer on March 31, 2025.
3. Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date
Remarks:
/s/ Stephen C. Petrovich, Attorney-in-Fact 04/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Get the next $ARDT alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$ARDT

DatePrice TargetRatingAnalyst
12/17/2024$20.00Neutral
Analyst
11/6/2024$22.00 → $19.00Buy → Neutral
BofA Securities
10/11/2024$24.00Overweight
KeyBanc Capital Markets
8/12/2024$22.00Buy
BofA Securities
8/12/2024$18.00Buy
Loop Capital
8/12/2024$24.00Overweight
Stephens
8/12/2024$21.00Buy
Citigroup
8/12/2024$23.00Outperform
RBC Capital Mkts
More analyst ratings

$ARDT
Press Releases

Fastest customizable press release news feed in the world

See more
  • Ardent Health Appoints Robert DeMichiei to Board of Directors

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

    $AP
    $ARDT
    $HCAT
    $WAY
    Fluid Controls
    Industrials
    Hospital/Nursing Management
    Health Care
  • Ardent Health Announces Appointment of Chief Operating Officer and Senior Leadership Promotions

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His

    $ARDT
    Hospital/Nursing Management
    Health Care
  • Ardent Health Reports Fourth Quarter 2024 Results

    Ardent Health Partners, Inc. (NYSE:ARDT) ("Ardent Health" or the "Company"), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Operating and Financial Summary All comparisons are versus the same prior year period. See the footnotes to the Operating Statistics table of this press release for definitions of the metrics below and a full list of key operating metrics. Total Revenue $1.61 billion 19% growth Y/Y Net Income Attributable to Ardent Health $114 million Adjusted EBITDA(1) $183 million 213% growth Y/Y

    $ARDT
    Hospital/Nursing Management
    Health Care

$ARDT
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

See more

$ARDT
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

See more

$ARDT
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

See more

$ARDT
SEC Filings

See more

$ARDT
Leadership Updates

Live Leadership Updates

See more
  • Ardent Health Appoints Robert DeMichiei to Board of Directors

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Robert A. DeMichiei to its board of directors. A seasoned leader with over 30 years of experience in financial strategy, healthcare operations, and board governance, Mr. DeMichiei served as executive vice president and chief financial officer at the University of Pittsburgh Medical Center (UPMC) from 2004 to 2020. During his tenure, he played a pivotal role in driving UPMC's financial growth and led numerous strategic initiatives, including mergers and acquisitions, supply chain management, and revenue cycle improvements. Prior to joining U

    $AP
    $ARDT
    $HCAT
    $WAY
    Fluid Controls
    Industrials
    Hospital/Nursing Management
    Health Care
  • Ardent Health Announces Appointment of Chief Operating Officer and Senior Leadership Promotions

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the appointment of Dave Caspers as chief operating officer. In this new role, Caspers will oversee operations across Ardent Health, which includes 30 hospitals and 280 sites of care in six states. He will be responsible for executing on strategic growth initiatives and driving operational excellence at an enterprise level. Caspers will also lead efforts to further optimize and scale the company's consumer-centric operating model across new and existing markets. "We are pleased to welcome Dave to Ardent," said Ardent Health President and CEO Marty Bonick. "His

    $ARDT
    Hospital/Nursing Management
    Health Care
  • Ardent Health Appoints Dave Styblo to Lead Investor Relations

    Ardent Health (NYSE:ARDT) today announced the appointment of Dave Styblo as senior vice president of investor relations. In his new role, Styblo will oversee Ardent's investor relations program and serve as the primary liaison with investors, analysts and financial partners. Styblo brings more than 20 years of investment experience, including time as a sell-side analyst covering the healthcare industry. He previously served as a senior vice president at Jefferies for more than a decade as an equity research analyst with a focus on healthcare services and managed care stocks. Most recently, Styblo served as an independent investor relations advisor to healthcare companies. He began his c

    $ARDT
    Hospital/Nursing Management
    Health Care

$ARDT
Financials

Live finance-specific insights

See more
  • Ardent Health Announces Fourth Quarter and Full Year 2024 Results Conference Call and Webcast Date

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it will issue its fourth quarter and full year 2024 results after the market closes on Wednesday, February 26, 2025. A conference call will be held the following day, Thursday, February 27, 2025, at 9:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior

    $ARDT
    Hospital/Nursing Management
    Health Care
  • Ardent Health Acquires 18 Urgent Care Clinics Across New Mexico and Oklahoma

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced it has acquired 18 urgent care clinics across New Mexico and Oklahoma from NextCare Urgent Care. "Expanding our urgent care footprint represents significant progress in our mission to create a consumer-focused ecosystem of care in each of the communities we serve," said Ardent Health President and CEO Marty Bonick. "We're helping patients receive the care they need, when and where they need it, by increasing access to convenient, high-quality services. These additional access points also bring new patients into our network while creating enhanced capacity to

    $ARDT
    Hospital/Nursing Management
    Health Care
  • Ardent Health Announces Third Quarter 2024 Results Conference Call and Webcast Date

    Ardent Health (NYSE:ARDT), a leading provider of healthcare in growing midsize urban communities across the U.S., today announced it will issue its third quarter 2024 results after the market closes on Wednesday, November 6, 2024. A conference call will be held the following day, Thursday, November 7, 2024, at 9:00 a.m. ET to review the Company's financial results, discuss recent events and conduct a question-and-answer session. A webcast of the conference call and accompanying presentation materials will be available in the Investor Relations section of Ardent's website at https://ir.ardenthealth.com. To listen to a live broadcast, go to the site at least 15 minutes prior to the scheduled

    $ARDT
    Hospital/Nursing Management
    Health Care

$ARDT
Large Ownership Changes

This live feed shows all institutional transactions in real time.

See more